Tubulis
Description: Tubulis develops advanced protein-drug conjugates for cancer treatment, leveraging proprietary tech to improve ADC therapies & patient outcomes.
Country: Germany
Based in: Munich
Founded: 2019
Funding Stage: Series A/B
Tags: ['Biotechnology', 'Health Care', 'Life Science', 'Pharmaceutical', 'Therapeutics']
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.
